Latest news
Loading news…
Novartis
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Basel, Basel-Stadt, Switzerland Founded 1996 10001+ employees
Novartis is a pharmaceutical company that researches and develops medicines for serious diseases to improve and extend people's lives.
Novartis on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$4.48B
Funding Rounds
3
Last Funding
Acquisitions
43
Monthly Visits
Contacts
10,000
Ticker
NVS
NYSE - New York Stock Exchange
Patents
9,255
6,831 trademarks
About Novartis
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- NVS
- Exchange
- NYSE - New York Stock Exchange
- IPO date
- May 19, 2000
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 194
- Mobile apps
- 1
- Active products
- 44
- Patents granted
- 9,255
- Trademarks
- 6,831
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $1.18B
Company Info
- Founded
- 1996
- Employees
- 10001+
- Operating status
- Active
- Org types
- company
- Founders
- 4
- Sub-organizations
- 10
- News articles
- 10,566
- Events
- 20
- HQ
- Basel, Basel-Stadt, Switzerland
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- May 19, 2000
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.5
- Trend (30d)
- 7
- Trend (90d)
- 3.2
- Last leadership hire
- Jun 24, 2026
- Last layoff mention
- May 6, 2026
Novartis Funding Rounds
3 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–3 of 3Show
Page 1 / 1
Novartis Acquisitions
44 results
| Acquiree Name | Acquirer Name | Acquisition Type | Acquisition Terms | Acquiree Industries | Acquiree Hq City | Acquiree Hq Country | Acquiree Description | Acquiree Number Of Employees | Acquirer Industries | Acquirer Hq Country | Acquirer Number Of Employees | Acquirer Ipo Status | Acquiree Website | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Myricx Bio | $1.1B | 2026-07-06 | Novartis | Acquisition | Cash | BiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics | London | United Kingdom | Myricx Bio is a biotechnology company that develops novel NM… | 2019-01-01 | 11-50 | BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine | Switzerland | 10001+ | Public | 43 | myricxbio.com | |
| Excellergy | $2B | 2026-03-27 | Novartis | Acquisition | — | BiotechnologyHealth CareMedical | Palo Alto | United States | Excellergy develops immunology-based therapies focused on tr… | — | — | BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine | Switzerland | 10001+ | Public | 43 | excellergy.com | |
| Pikavation Therapeutics | $2B | 2026-03-20 | Novartis | Acquisition | Cash | Therapeutics | — | — | Pikavation Therapeutics is a wholly owned subsidiary of Synn… | — | — | BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine | Switzerland | 10001+ | Public | 43 | — | |
| Avidity Biosciences | $12B | 2025-10-26 | Novartis | Merger | Cash | BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics | San Diego | United States | Synapse Energy Economics is a consulting firm providing econ… | 2013-01-01 | 251-500 | BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine | Switzerland | 10001+ | Public | 43 | www.aviditybiosciences.com | |
| Tourmaline Bio | $1.4B | 2025-09-09 | Novartis | Merger | Cash | BiotechnologyClinical TrialsTherapeutics | New York | United States | Tourmaline Bio is a biotechnology company that develops medi… | — | — | BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine | Switzerland | 10001+ | Public | 43 | www.tourmalinebio.com |
1–5 of 44Show
Page 1 / 9
10,000
professional contacts at Novartis
Contact execs at Novartis →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Novartis
Loading news…
FAQs about Novartis
People who checked this page also checked these
Sectors Novartis invests & acquires in
Browse the full Acquirezy directory.